Truvada HIV Giveaway Program Faces Psychological Stigma in Young At-Risk Adults

There are reasons why young adults ignore facts and engage in high-risk sexual behavior

Truvada Bone Lawsuit News

Wednesday, July 31, 2019 - Even though AIDS is a physical disease that attacks and destroys the immune system, it may be the psychological aspects of it that prove most destructive. Truvada, a pre-exposure prophylaxis drug aimed at preventing the transmission of HIV, the virus that leads to AIDS, is highly effective. Studies indicate that up to 99% of those taking the drug remain HIV negative. The Center for Disease Control estimates that around 10% of young adults in the high-risk group are taking the drug. According to San Francisco's Bay Area Reporter, "The Center for Disease Control and Prevention estimates, only around 10% of the more than 1.1 million people in the United States who are at substantial risk for HIV are using PrEP. This drops to just 1% among African Americans, the group with the highest rate of new infections." Truvada lawsuit lawyers have vast experience and are experts at handling cases against multinational pharmaceutical conglomerates and achieving justice on behalf of American families harmed by negligence and corporate greed.

Young adults associate the drug Truvada with AIDS and avoid the stigma associated with having to take the drug. Even though one would assume that teenage gay black, and Latino men who comprise the highest risk demographic would jump at the chance to protect themselves from the deadly virus, most gay black and Latino teenagers either fear the social stigma that is attached with the virus or are unaware that they are at risk for HIV. It is incorrectly assumed that only those who know that their sexual partner is HIV positive would seek to take the drug. More must be done on the junior high school and high school level to make Truvada discretely available to this high-risk group. Not only is educating them to take the drug a problem but also the costs of follow up visits to doctors to monitor patients for Truvada's side effects can cost over $500 per month. Truvada patients are at risk of developing brittle bones that lead to spontaneous fractures as well as renal disease and kidney failure.

Some experts are against the promotion of Truvada pointing out that while the drug may decrease the rate of HIV transmissions, it also promotes sexual enjoyment visa vie unprotected sexual activities which can lead to the spread of other deadly sexually transmitted infections as well as increase the rate of unwanted pregnancies. Researchers write in the National Institute of Health (NIH) that the stigma of being stereotyped will probably prevent the Truvada programs to be ineffective. According to the NIH, "concern about sexual risk behavior increasing with PrEP use (risk compensation) and corresponding stereotypes of promiscuity may undermine PrEP's preventive potential."

Truvada is to be made available to those without insurance and those who cannot afford it free of charge. Gilead Pharmaceuticals is working with the Trump Administration to make 2.4 million bottles of the HIV prevention drug available for free every year for the next 10 to 15 years. Lawmakers in Congress feel that the initiative is not nearly enough and that the drug's patient should be "nationalized" and the drug given away for free in unlimited quantities. The rationale is that the HIV/AIDS crisis presents a public security threat and also that Truvada was developed using government grant money, making the US taxpayer rightful patent owner.

More Recent Truvada Bone Lawsuit News:

No-Cost, No-Obligation Truvada Lawsuit Case Review If You or a Loved One Suffered from Truvada Bone or Kidney Complications

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.